Nanotechnology and Oncology Workshop Summary

Gespeichert in:
Bibliographische Detailangaben
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Washington, D.C. National Academies Press 2011
Schlagworte:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000zc 4500
001 BV045344489
003 DE-604
005 00000000000000.0
007 cr|uuu---uuuuu
008 181206s2011 xx a||| o|||| 00||| eng d
020 |a 9780309163224  |9 978-0-309-16322-4 
020 |a 0309163226  |9 0-309-16322-6 
020 |a 1283151731  |9 1-283-15173-1 
020 |a 9781283151733  |9 978-1-283-15173-3 
020 |z 9786613151735  |9 9786613151735 
020 |z 6613151734  |9 6613151734 
035 |a (ZDB-4-ENC)ocn746945424 
035 |a (OCoLC)746945424 
035 |a (DE-599)BVBBV045344489 
040 |a DE-604  |b ger  |e rda 
041 0 |a eng 
082 0 |a 610.28  |2 23 
245 1 0 |a Nanotechnology and Oncology  |b Workshop Summary  |c Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies 
264 1 |a Washington, D.C.  |b National Academies Press  |c 2011 
300 |a 1 online resource (xii, 106 pages)  |b illustrations 
336 |b txt  |2 rdacontent 
337 |b c  |2 rdamedia 
338 |b cr  |2 rdacarrier 
500 |a Print version record 
505 8 |a "One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website 
650 7 |a MEDICAL / Allied Health Services / Medical Technology  |2 bisacsh 
650 7 |a MEDICAL / Biotechnology  |2 bisacsh 
650 7 |a MEDICAL / Family & General Practice  |2 bisacsh 
650 7 |a MEDICAL / Lasers in Medicine  |2 bisacsh 
650 7 |a TECHNOLOGY & ENGINEERING / Biomedical  |2 bisacsh 
650 7 |a Cancer / Treatment  |2 fast 
650 7 |a Nanomedicine  |2 fast 
650 7 |a Nanotechnology  |2 fast 
650 7 |a Oncology / Research  |2 fast 
650 4 |a Neoplasms / therapy / Congresses 
650 4 |a Nanomedicine  |v Congresses  |a Oncology  |x Research  |z United States  |v Congresses  |a Nanotechnology  |v Congresses  |a Cancer  |x Treatment  |v Congresses 
655 7 |8 1\p  |0 (DE-588)1071861417  |a Konferenzschrift  |2 gnd-content 
700 1 |a Patlak, Margie  |e Sonstige  |4 oth 
700 1 |a Micheel, Christine  |e Sonstige  |4 oth 
710 2 |a Institute of Medicine (U.S.)  |e Sonstige  |4 oth 
710 2 |a National Cancer Policy Forum (U.S.)  |e Sonstige  |4 oth 
776 0 8 |i Erscheint auch als  |n Druck-Ausgabe  |t Nanotechnology and oncology  |d Washington, D.C. : National Academies Press, 2011  |z 0309163218 
912 |a ZDB-4-ENC 
883 1 |8 1\p  |a cgwrk  |d 20201028  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
943 1 |a oai:aleph.bib-bvb.de:BVB01-030731193 

Datensatz im Suchindex

_version_ 1819303908081664000
any_adam_object
building Verbundindex
bvnumber BV045344489
collection ZDB-4-ENC
contents "One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website
ctrlnum (ZDB-4-ENC)ocn746945424
(OCoLC)746945424
(DE-599)BVBBV045344489
dewey-full 610.28
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 610 - Medicine and health
dewey-raw 610.28
dewey-search 610.28
dewey-sort 3610.28
dewey-tens 610 - Medicine and health
discipline Medizin
format Electronic
eBook
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03569nam a2200565zc 4500</leader><controlfield tag="001">BV045344489</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">181206s2011 xx a||| o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309163224</subfield><subfield code="9">978-0-309-16322-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309163226</subfield><subfield code="9">0-309-16322-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1283151731</subfield><subfield code="9">1-283-15173-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781283151733</subfield><subfield code="9">978-1-283-15173-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9786613151735</subfield><subfield code="9">9786613151735</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">6613151734</subfield><subfield code="9">6613151734</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-ENC)ocn746945424</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)746945424</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045344489</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610.28</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nanotechnology and Oncology</subfield><subfield code="b">Workshop Summary</subfield><subfield code="c">Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xii, 106 pages)</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Print version record</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">"One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Allied Health Services / Medical Technology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Biotechnology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Family &amp; General Practice</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Lasers in Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TECHNOLOGY &amp; ENGINEERING / Biomedical</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanomedicine</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanotechnology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oncology / Research</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / therapy / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanomedicine</subfield><subfield code="v">Congresses</subfield><subfield code="a">Oncology</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield><subfield code="a">Nanotechnology</subfield><subfield code="v">Congresses</subfield><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Patlak, Margie</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Micheel, Christine</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Forum (U.S.)</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="t">Nanotechnology and oncology</subfield><subfield code="d">Washington, D.C. : National Academies Press, 2011</subfield><subfield code="z">0309163218</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-ENC</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030731193</subfield></datafield></record></collection>
genre 1\p (DE-588)1071861417 Konferenzschrift gnd-content
genre_facet Konferenzschrift
id DE-604.BV045344489
illustrated Illustrated
indexdate 2024-12-24T06:56:50Z
institution BVB
isbn 9780309163224
0309163226
1283151731
9781283151733
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-030731193
oclc_num 746945424
open_access_boolean
physical 1 online resource (xii, 106 pages) illustrations
psigel ZDB-4-ENC
publishDate 2011
publishDateSearch 2011
publishDateSort 2011
publisher National Academies Press
record_format marc
spelling Nanotechnology and Oncology Workshop Summary Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies
Washington, D.C. National Academies Press 2011
1 online resource (xii, 106 pages) illustrations
txt rdacontent
c rdamedia
cr rdacarrier
Print version record
"One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website
MEDICAL / Allied Health Services / Medical Technology bisacsh
MEDICAL / Biotechnology bisacsh
MEDICAL / Family & General Practice bisacsh
MEDICAL / Lasers in Medicine bisacsh
TECHNOLOGY & ENGINEERING / Biomedical bisacsh
Cancer / Treatment fast
Nanomedicine fast
Nanotechnology fast
Oncology / Research fast
Neoplasms / therapy / Congresses
Nanomedicine Congresses Oncology Research United States Congresses Nanotechnology Congresses Cancer Treatment Congresses
1\p (DE-588)1071861417 Konferenzschrift gnd-content
Patlak, Margie Sonstige oth
Micheel, Christine Sonstige oth
Institute of Medicine (U.S.) Sonstige oth
National Cancer Policy Forum (U.S.) Sonstige oth
Erscheint auch als Druck-Ausgabe Nanotechnology and oncology Washington, D.C. : National Academies Press, 2011 0309163218
1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk
spellingShingle Nanotechnology and Oncology Workshop Summary
"One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website
MEDICAL / Allied Health Services / Medical Technology bisacsh
MEDICAL / Biotechnology bisacsh
MEDICAL / Family & General Practice bisacsh
MEDICAL / Lasers in Medicine bisacsh
TECHNOLOGY & ENGINEERING / Biomedical bisacsh
Cancer / Treatment fast
Nanomedicine fast
Nanotechnology fast
Oncology / Research fast
Neoplasms / therapy / Congresses
Nanomedicine Congresses Oncology Research United States Congresses Nanotechnology Congresses Cancer Treatment Congresses
subject_GND (DE-588)1071861417
title Nanotechnology and Oncology Workshop Summary
title_auth Nanotechnology and Oncology Workshop Summary
title_exact_search Nanotechnology and Oncology Workshop Summary
title_full Nanotechnology and Oncology Workshop Summary Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies
title_fullStr Nanotechnology and Oncology Workshop Summary Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies
title_full_unstemmed Nanotechnology and Oncology Workshop Summary Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies
title_short Nanotechnology and Oncology
title_sort nanotechnology and oncology workshop summary
title_sub Workshop Summary
topic MEDICAL / Allied Health Services / Medical Technology bisacsh
MEDICAL / Biotechnology bisacsh
MEDICAL / Family & General Practice bisacsh
MEDICAL / Lasers in Medicine bisacsh
TECHNOLOGY & ENGINEERING / Biomedical bisacsh
Cancer / Treatment fast
Nanomedicine fast
Nanotechnology fast
Oncology / Research fast
Neoplasms / therapy / Congresses
Nanomedicine Congresses Oncology Research United States Congresses Nanotechnology Congresses Cancer Treatment Congresses
topic_facet MEDICAL / Allied Health Services / Medical Technology
MEDICAL / Biotechnology
MEDICAL / Family & General Practice
MEDICAL / Lasers in Medicine
TECHNOLOGY & ENGINEERING / Biomedical
Cancer / Treatment
Nanomedicine
Nanotechnology
Oncology / Research
Neoplasms / therapy / Congresses
Nanomedicine Congresses Oncology Research United States Congresses Nanotechnology Congresses Cancer Treatment Congresses
Konferenzschrift
work_keys_str_mv AT patlakmargie nanotechnologyandoncologyworkshopsummary
AT micheelchristine nanotechnologyandoncologyworkshopsummary
AT instituteofmedicineus nanotechnologyandoncologyworkshopsummary
AT nationalcancerpolicyforumus nanotechnologyandoncologyworkshopsummary